Copyright © Fidelis Security. All rights reserved.
-
Privacy PolicyPrivacy Policy
-
Terms of ServiceTerms of Service
-
Trust CenterTrust Center
-
SecuritySecurity
Get the latest insights and information from the world of cybersecurity to help you fortify your defenses!
Lyell Immunopharma is a South San Francisco-based, publicly traded cell therapy company (LYEL). Their T cell reprogramming technology focuses on the mastery of T cells to cure patients with solid tumors. They apply proprietary genetic and epigenetic reprogramming technology platforms to address barriers present in solid tumors in order to develop new medicines with improved, durable, and potentially curative clinical outcomes.
Explore MITRE ATT&CK Evaluation insights with Fidelis Security's whitepaper. Understand...
Read WhitepaperDiscover how to combat cyber threats effectively with Fidelis Elevate....
Read WhitepaperExplore Network Detection and Response (NDR) insights in this whitepaper....
Read WhitepaperBalancing Act: Your Role in Cloud Security Responsibilities In a...
Read WhitepaperLearn how to detect and manage post-breach attacks, understand your...
Read WhitepaperLearn mindset shifts, environment understanding, platform expectations, consolidation, and more.
Read WhitepaperDiscover motives, tactics, and security solutions for mastering Active Directory...
Read WhitepaperJoin our newsletter to stay up to date on features and releases.